Dawnrays Pharmaceutical (Holdings) Limited

Announcements & Notices       

2023-August-27	INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2023 AND CLOSURE OF REGISTER OF MEMBERS (in PDF)
2023-August-25	ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023 (in PDF)
2023-August-14	DATE OF BOARD MEETING (in PDF)
2023-June-2	VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION HAS ACCEPTED THE NEW DRUG APPLICATION FOR EBRONUCIMAB INJECTION (ANTI-PCSK9 MONOCLONAL ANTIBODY, AK102) DEVELOPED BY AD PHARMACEUTICALS (in PDF)
2023-May-25	POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 MAY 2023 (in PDF)
2023-April-25	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2023-March-26	FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022 AND CLOSURE OF REGISTER OF MEMBERS (in PDF)
2023-March-26	ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022 (in PDF)
2023-March-10	DATE OF BOARD MEETING (in PDF)
2023-February-28	Terms of Reference of Remuneration Committee (in PDF)
2023-February-28	Terms of Reference of Audit Committee (in PDF)
2024	2024 Announcements & Notices
2022	2022 Announcements & Notices
2021	2021 Announcements & Notices
2020	2020 Announcements & Notices
2019	2019 Announcements & Notices
2018	2018 Announcements & Notices
2017	2017 Announcements & Notices